Gregory A Jarvis, PAAA | |
9200 W Wisconsin Ave, Milwaukee, WI 53226-3522 | |
(414) 805-8700 | |
(414) 259-1522 |
Full Name | Gregory A Jarvis |
---|---|
Gender | Male |
Speciality | Anesthesiology Assistant |
Experience | 12 Years |
Location | 9200 W Wisconsin Ave, Milwaukee, Wisconsin |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1972854644 | NPI | - | NPPES |
1972854644 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367H00000X | Anesthesiologist Assistant | 006538 (Georgia) | Secondary |
367H00000X | Anesthesiologist Assistant | 106 (Wisconsin) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Emory University Hospital Midtown | Atlanta, GA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
The Emory Clinic, Inc | 8820901408 | 2687 |
News Archive
Bacteria are experts at adaptation: as soon as they have infected an organism, they adapt their metabolism to that of their host and produce substances which protect them from the body's immune defences. How they do this is still unknown in the case of many types of bacteria.
Heart disease is the leading cause of mortality in women worldwide, including in the United States. Although deaths from cardiovascular disease (CVD) in men have declined since the 1970s, the rates of death for women have not followed.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the rheumatoid arthritis drug market in India will more than double by 2013, growing from $296 million in 2008 to $672 million in 2013.
Although patients with rheumatoid arthritis have a disproportionately higher incidence of herpes zoster (shingles), an analysis that included nearly 60,000 patients with RA and other inflammatory diseases found that those who initiated anti-tumor necrosis factor therapies were not at higher risk of herpes zoster compared with patients who initiated nonbiologic treatment regimens, according to a study appearing in the March 6 issue of JAMA.
Some drugmakers assert they are unable to create cheaper generic versions of drugs because their rivals are exploiting a legal loophole. It all comes down to process: To get a generic drug approved for sale, a company has to test a sample of the brand-name version and show regulators that the generic version is essentially identical and as effective.
› Verified 8 days ago
Entity Name | The Emory Clinic Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396798229 PECOS PAC ID: 8820901408 Enrollment ID: O20031110000503 |
News Archive
Bacteria are experts at adaptation: as soon as they have infected an organism, they adapt their metabolism to that of their host and produce substances which protect them from the body's immune defences. How they do this is still unknown in the case of many types of bacteria.
Heart disease is the leading cause of mortality in women worldwide, including in the United States. Although deaths from cardiovascular disease (CVD) in men have declined since the 1970s, the rates of death for women have not followed.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the rheumatoid arthritis drug market in India will more than double by 2013, growing from $296 million in 2008 to $672 million in 2013.
Although patients with rheumatoid arthritis have a disproportionately higher incidence of herpes zoster (shingles), an analysis that included nearly 60,000 patients with RA and other inflammatory diseases found that those who initiated anti-tumor necrosis factor therapies were not at higher risk of herpes zoster compared with patients who initiated nonbiologic treatment regimens, according to a study appearing in the March 6 issue of JAMA.
Some drugmakers assert they are unable to create cheaper generic versions of drugs because their rivals are exploiting a legal loophole. It all comes down to process: To get a generic drug approved for sale, a company has to test a sample of the brand-name version and show regulators that the generic version is essentially identical and as effective.
› Verified 8 days ago
Entity Name | Emory Specialty Associates, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1407864168 PECOS PAC ID: 3476559782 Enrollment ID: O20061010000447 |
News Archive
Bacteria are experts at adaptation: as soon as they have infected an organism, they adapt their metabolism to that of their host and produce substances which protect them from the body's immune defences. How they do this is still unknown in the case of many types of bacteria.
Heart disease is the leading cause of mortality in women worldwide, including in the United States. Although deaths from cardiovascular disease (CVD) in men have declined since the 1970s, the rates of death for women have not followed.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the rheumatoid arthritis drug market in India will more than double by 2013, growing from $296 million in 2008 to $672 million in 2013.
Although patients with rheumatoid arthritis have a disproportionately higher incidence of herpes zoster (shingles), an analysis that included nearly 60,000 patients with RA and other inflammatory diseases found that those who initiated anti-tumor necrosis factor therapies were not at higher risk of herpes zoster compared with patients who initiated nonbiologic treatment regimens, according to a study appearing in the March 6 issue of JAMA.
Some drugmakers assert they are unable to create cheaper generic versions of drugs because their rivals are exploiting a legal loophole. It all comes down to process: To get a generic drug approved for sale, a company has to test a sample of the brand-name version and show regulators that the generic version is essentially identical and as effective.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Gregory A Jarvis, PAAA 9200 W Wisconsin Ave, Milwaukee, WI 53226-3522 Ph: (414) 805-8700 | Gregory A Jarvis, PAAA 9200 W Wisconsin Ave, Milwaukee, WI 53226-3522 Ph: (414) 805-8700 |
News Archive
Bacteria are experts at adaptation: as soon as they have infected an organism, they adapt their metabolism to that of their host and produce substances which protect them from the body's immune defences. How they do this is still unknown in the case of many types of bacteria.
Heart disease is the leading cause of mortality in women worldwide, including in the United States. Although deaths from cardiovascular disease (CVD) in men have declined since the 1970s, the rates of death for women have not followed.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the rheumatoid arthritis drug market in India will more than double by 2013, growing from $296 million in 2008 to $672 million in 2013.
Although patients with rheumatoid arthritis have a disproportionately higher incidence of herpes zoster (shingles), an analysis that included nearly 60,000 patients with RA and other inflammatory diseases found that those who initiated anti-tumor necrosis factor therapies were not at higher risk of herpes zoster compared with patients who initiated nonbiologic treatment regimens, according to a study appearing in the March 6 issue of JAMA.
Some drugmakers assert they are unable to create cheaper generic versions of drugs because their rivals are exploiting a legal loophole. It all comes down to process: To get a generic drug approved for sale, a company has to test a sample of the brand-name version and show regulators that the generic version is essentially identical and as effective.
› Verified 8 days ago
Justin Michael Cole, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 2901 W Kinnickinnic River Pkwy Ste 305, Milwaukee, WI 53215 Phone: 414-649-6000 | |
Mackenzie Lynn Reid, AA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-8700 Fax: 414-259-1522 | |
Aysha T Muhammad, CAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-8700 Fax: 414-259-1522 | |
Anjali Rajan Menon, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-8700 Fax: 414-259-1522 | |
Joseph Shaoul, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 945 N 12th St, Milwaukee, WI 53233 Phone: 414-219-2000 | |
Mrs. Lea Van Heule, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 2900 W Oklahoma Ave, Milwaukee, WI 53215 Phone: 231-288-3155 | |
Sarah Anderson, AA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 2900 W Oklahoma Ave, Milwaukee, WI 53215 Phone: 414-649-6000 |